incb086550
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 10, 2018 (NCT03762447)
Timeline
Indications
Mechanism of action
- Programmed cell death 1 ligand 1INHIBITOR
CD274 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05101369 | Phase 1 | Dec 13, 2021 | Incyte |
| NCT04629339 | Phase 2 | Dec 31, 2020 | Incyte |
| NCT04674748 | Phase 1 | Dec 15, 2020 | Incyte |
| NCT03762447 | Phase 1 | Dec 10, 2018 | Incyte |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 4 | 4 | 2 | 2018 |
1 organizations
Page 1 / 1